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Aim: To assess the repeatability of Eger macular stressometer
(EMS) measures of photostress recovery and determine their
association with other measures of visual function.
Methods: EMS photostress recovery time was measured in
90 patients with bilateral exudative age related macular
degeneration (AMD), 19 with bilateral atrophic AMD and 47
with both forms of the condition (mean age 79 (SD 13)
years). Measurements were made on two occasions sepa-
rated by 1 year. Intrasession repeatability was assessed by
repeating the measures after a 10 minute recovery period at
the first visit. Distance visual acuity was measured with a
logMAR chart, near visual acuity with a MNRead chart at
25 cm, contrast sensitivity with a Pelli-Robson chart, and the
presence of central visual disturbance assessed with an
Amsler grid. A questionnaire was used to assess self reported
difficulties with glare recovery.
Results: The average EMS recovery time was 11.0 (SD 8.9)
seconds, decreasing by 1.6 (5.2) seconds on repeated
measurement (p,0.05). EMS photostress recovery was not
correlated with visual function measures or subjective
difficulties with lights (p.0.05). EMS photostress recovery
time did not predict those whose vision decreased over the
following year compared with those among whom it
remained stable.
Conclusions: The EMS test is not a useful tool in determining
the severity or progression of AMD.
T
he photostress test involves exposing the eye to intense
light for a set duration of time and measuring the time
taken for visual acuity to recover to a predetermined
level.1 The reduction in visual acuity results from photopig-
ment depletion and the recovery time are dependent on the
rate of photopigment regeneration.1 The time course for dark
adaptation is delayed for both rods and cones over the entire
stimulated retina and not just in the macular region.2
A variety of photostress tests have been advocated and
assessed including pen torches, ophthalmoscopes,
Maxwellian view optical systems, pupilometers, scanning
laser ophthalmoscopes, and visually evoked potentials.3–5
Photostress recovery time has been shown to increase in
patients with macular conditions such as central serous
retinopathy, cystoid macular oedema and age related macular
degeneration (AMD).6–9
There are reports that photostress recovery time is sensitive
to the early stages of atrophic AMD6 8 9 and can be used to
predict second eye development of choroidal neovascular
membranes.10 However, studies examining photostress recov-
ery time in AMD have generally assessed few patients and
there has been a lack of standardisation between techni-
ques.6–9 11 12
Few studies to date have related photostress recovery time
to subjective symptoms in AMD. Collins and Brown7 reported
a correlation between subjective adaptation difficulties at
night and prolonged glare recovery times. However, only two
of their 10 participants with AMD reported difficulty
adjusting to the dark when walking outside at night. No
association was found with either headlight glare when
driving at night or adjusting to sudden changes in light level
when walking indoors on a sunny day.
Two published studies13 14 have examined the commercially
available Eger macular stressometer test (EMS; Gulden
Ophthalmics, PA, USA). Bartlett and colleagues found that
patients with age related maculopathy (n = 17) and AMD
(n = 12) had significantly longer EMS photostress recovery
times compared to age matched controls.13 However, Schmitt
and co-workers showed no difference between cataract
(n = 30), diabetic retinopathy (n = 16), glaucoma (n = 16),
and AMD patients (n = 30).14 Only one patient with
exudative AMD was assessed between these two studies
combined.
This study aimed to measure photostress recovery time
using the EMS test and to assess measurement repeatability
in a large cohort including both atrophic and exudative AMD
patients. The correlation between subjectively reported glare
problems and EMS photostress recovery time and the ability
of the EMS to predict those whose visual acuity or contrast
sensitivity will deteriorate over the subsequent year were also
determined.
METHODS
The mean age of the 156 participants recruited from the
Queen’s Medical Centre, Nottingham was 78.96 (SD 6.64)
years (64% female). Patients were considered suitable if they
had AMD irrespective of severity or duration, treated or
untreated, in one (n = 6; 3.8%) or both eyes. Exclusion
criteria were eye disease other than AMD and inability to
understand or speak English. Ninety people (57.7%) had
exudative AMD, 19 (12.2%) had atrophic AMD and the
remaining patients a combination of the two forms of the
disease. All gave informed consent to take part in the study,
which was approved by the local research ethics committee
(Nottingham) and adhered to the tenets of the Declaration of
Helsinki.
The EMS consists of a Thyristor photo flash linked to a
digital timer and a near acuity chart. Patients, with vision
best corrected by their reading prescription, read the smallest
logMAR near acuity line of capital letters at 40 cm
(illuminated by 900 lux) using binocular vision. The EMS
was then moved to 15 cm and the patients binocularly
exposed to the flash while looking into its centre (visual
angle 14.2˚horizontally and 6.8˚vertically). The reading chart
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was immediately repositioned at 40 cm and time until the
patient could read print one line (0.1 logMAR) larger than
their pre-exposure visual acuity was measured. The measure-
ment was repeated after a 10 minute recovery period to allow
retinal re-adaptation following bleaching.13 15
Distance and near (25 cm working distance) visual acuity
was measured using Bailey-Lovie logMAR charts. Contrast
sensitivity was assessed using Pelli-Robson charts and the
presence of central distortion or scotoma with an Amsler grid.
Subjective difficulties with vision in bright sunlight, adapting
to bright sunlight, adapting to dim light, being dazzled by
bright lights and having to shade their eyes because of
excessive light were each rated on a six point scale.
The EMS recovery time and visual function assessment
was remeasured after 1 year in 135 participants. Progression
of distance visual acuity was taken as a reduction in logMAR
of .0.1 units (95% confidence interval of repeatability).16
Progression of contrast sensitivity loss was taken as a
reduction exceeding 0.3 Pelli-Robson log units (95% con-
fidence interval of repeatability).17 All results are presented as
means (SD).
RESULTS
Averaged across the full sample of patients, EMS recovery
time was 11.0 (SD 8.9) seconds. The visual function of the
three AMD groups is given in table 1. The relation between
visual acuity and EMS result is shown in figure 1. EMS
recovery time was 1.6 (5.2) seconds shorter on intrasession
repeated measure (p,0.05). Initial EMS photostress recovery
was not correlated with distance visual acuity in all three
AMD groups (p.0.05). This was also the case for contrast
sensitivity (fig 2) and near visual acuity. Those patients with
a central visual field defect or distortion had a similar EMS
photostress recovery time as those with an intact central
visual field in exudative (p = 0.56), atrophic (p = 0.38), or
mixed AMD (p = 0.10). Subjective difficulties with vision
were unrelated to EMS photostress recovery time in all three
AMD groups (p.0.05).
EMS recovery time and visual function were assessed again
after a 1 year period. There was no difference in the initial
EMS photostress recovery time among patients with exuda-
tive AMD whose distance visual acuity (10.6 (8.7) v 7.9 (3.4)
seconds, p = 0.15) or contrast sensitivity (10.8 (9.4) v 11.1
(7.5) seconds, p = 0.92) deteriorated compared with those
among whom these two measures remained stable. There
was also no difference between the change in EMS
photostress recovery time over 1 year in those with exudative
AMD whose distance visual acuity (3.3 (10.9) v 2.0 (4.1)
seconds, p = 0.28) or contrast sensitivity (4.3 (9.4) v 4.1 (9.1)
log units, p = 0.99) deteriorated compared with those in
whom these two measures remained stable. Too few patients
in the atrophic or mixed AMD groups had a decrease in
distance visual acuity or contrast sensitivity (n = 4/3 and
n = 11/3, respectively) for a statistical analysis to be
performed.
DISCUSSION
Our results provide no evidence that EMS photostress
recovery time is affected by AMD, contrary to previous
reports using other photostress techniques.6–9 11 12 Indeed, the
average EMS recovery time in our study was similar to that
found in previous studies using similar short exposure flash
in healthy patients.13 18 The EMS mean recovery time is
generally lower than that obtained with other techniques for
measuring photostress recovery time,1 6–9 11 12 which suggests
the device does not bleach sufficient photopigment to
challenge outer retinal physiology and hence identify people
with AMD. The coefficient of repeatability of 10.2 seconds in
this study was larger than that found by Bartlett and
colleagues13 using the EMS test in a younger population
without eye disease, although there was a similar decrease in
recovery time with repeated measurement. However, the
Bartlett study found significantly longer recovery times in
AMD. We are unable to speculate on the differences between
these studies, as the central field status of patients was not
reported in the Bartlett study. The EMS large coefficient of
repeatability limits the sensitivity of the test.
The EMS photostress recovery was not correlated with
visual function measures or subjective difficulties with lights
Table 1 Visual function of the three age related macular degeneration (AMD) groups
Exudative
AMD
Atrophic
AMD
Mixed
AMD
Distance visual acuity (logMAR) 0.60 (0.39) 0.08 (0.39) 0.07 (0.38)
Contrast sensitivity (log units) 0.87 (0.45) 1.14 (0.45) 1.26 (0.29)
Near visual acuity (logMAR) 0.54 (0.43) 0.31 (0.48) 0.23 (0.23)
Central visual field defect (%) 65 42 44
EMS recovery time (seconds) 10.1 (8.7) 14.7 (10.6) 11.3 (8.6)
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Figure 1 Photostress recovery time (seconds) as a function of distance
visual acuity in exudative, atrophic, and mixed atrophic and exudative
AMD (n = 156).
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Figure 2 Photostress recovery time (seconds) as a function of contrast
sensitivity in exudative, atrophic, and mixed atrophic and exudative
AMD (n = 156).
Eger macular stressometer evaluation 433
www.bjophthalmol.com
and changing light conditions in AMD. There was also no
difference in the initial EMS photostress recovery time or
change over a year in recovery time among those whose
vision decreased over the following year compared with those
among whom it remained stable. It would therefore appear
that photostress recovery time as assessed by the EMS test is
not a useful tool in determining either the severity or the
progression of AMD.
The transient state of insensitivity subjectively perceived
after photostress is experienced as a scotomatous afterimage.6
The amount of photopigment bleached is dependent on the
intensity and duration of the flash.19 In addition, pupil size
and eccentricity of viewing will affect the result. Elderly
patients tend to have smaller pupils and therefore may need
longer exposure to the light source for the photoreceptors to
be fully bleached. Furthermore, patients with AMD often
adopt eccentric viewing and therefore the effect may be
further reduced.1 As such, redesign of the test with a longer
flash duration of greater visual angle may be appropriate.
Bleaching the photoreceptors with a direct ophthalmoscope
for 30 seconds has been suggested to be the most reliable test
of photostress as more photopigment is bleached and the
effect of pupil size is limited.1 However, the EMS test has a
short assessment time and patients relate to the difficulty of
adapting after a flash or sudden change in lighting. Hence,
despite the negative findings of this study, if redesign and
further development of the EMS test could produce associa-
tions with the severity and progression of AMD, it may be an
attractive test in clinical practice.
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